VNRX•benzinga•
VolitionRx Announces Pricing Of Up To $2.3M Registered Direct Offering Up Front At $0.55 Per Share With Up To An Additional $1.1M Of Potential Aggerate Gross Proceeds
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on March 26, 2025 by benzinga